Skip to main content
. Author manuscript; available in PMC: 2015 Apr 23.
Published in final edited form as: Transplantation. 2014 Jun 27;97(12):1209–1215. doi: 10.1097/TP.0000000000000093

TABLE 2.

Anti-xenogeneic and anti-allogeneic lgG antibodya, and anti-xenogeneic and anti-allogeneic cytotoxicityb

Baboon ID Pre-MFI
Anti-Xeno
Pre-MFI
Anti-Allo
Anti-Xeno
Post 1°
Anti-Allo
Post 1°
Anti-Xeno
Post 2°
Anti- Alio
Post 2°
Precytotox
Anti-Xeno
Precytotox
Anti-Allo
Anti-Xeno
Post 1°
Anti-Allo
Post 1°
Anti-Xeno
Post 2°
Anti-Allo
Post 2°
Group 1: primary alio; secondary xeno
8321     1   1      16   1    225 55 1:2 1:2   1:512   1:512 >1:1024 1:512
8322 183   1    202   1 1,275 22 1:8 1:2   1:16   1:128   1:256 1:128
83411 149   4    158   7 1,252 40 1:32 1:2   1:64 >1:1024 >1:1024 1:512
83511   29   4      20 69 1,114 28 1:64 1:2   1:64   1:64 >1:1024 1:512
Group 2: primary xeno; secondary alio
8297     3   4      17   6      10   4 1:2 ND   1:64   ND   1:16 ND
81011 305 15 1,286 11 1,433 14 1:16 1:2   1:512   1:2   1:256 1:32
83811     9   4    426   5    552   5 1:32 1:2 >1:1024   1:2   1:256 1:1024
83911   62   8    791   9 1,526 57 1:64 1:2 >1:1024   1:16 >1:1024 1:1024
a

Anti-xenogeneic and allogeneic antibody binding data is shown as the mode of fluorescence intensity (MFI) of IgG antibody binding.

b

The cytotoxicity titer is defined as the dilution after which percentage cytotoxicity falls below 50% of maximum. ND designates that the assay was not done. B297* had an abnormal antibody response, in comparison to other animals, producing IgM (MFI=169) but low IgG (MFI=14).